LIFEMD INC (LFMD) Stock Price, Forecast & Analysis

NASDAQ:LFMD • US53216B1044

2.78 USD
-0.02 (-0.71%)
At close: Feb 13, 2026
2.83 USD
+0.05 (+1.8%)
After Hours: 2/13/2026, 8:21:36 PM

LFMD Key Statistics, Chart & Performance

Key Statistics
Market Cap133.83M
Revenue(TTM)252.34M
Net Income(TTM)-7.71M
Shares48.14M
Float39.55M
52 Week High15.84
52 Week Low2.72
Yearly Dividend0.08
Dividend Yield0%
EPS(TTM)-0.14
PEN/A
Fwd PEN/A
Earnings (Next)03-09
IPO2001-07-11
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
LFMD short term performance overview.The bars show the price performance of LFMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

LFMD long term performance overview.The bars show the price performance of LFMD in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 -60

The current stock price of LFMD is 2.78 USD. In the past month the price decreased by -26.26%. In the past year, price decreased by -63.71%.

LIFEMD INC / LFMD Daily stock chart

LFMD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
LFMD Full Technical Analysis Report

LFMD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to LFMD. While LFMD seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
LFMD Full Fundamental Analysis Report

LFMD Financial Highlights

Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.14. The EPS increased by 78.13% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -11.68%
ROE -586.53%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%12.7%
EPS 1Y (TTM)78.13%
Revenue 1Y (TTM)30.71%
LFMD financials

LFMD Forecast & Estimates

14 analysts have analysed LFMD and the average price target is 9.44 USD. This implies a price increase of 239.39% is expected in the next year compared to the current price of 2.78.

For the next year, analysts expect an EPS growth of 61.09% and a revenue growth 15.11% for LFMD


Analysts
Analysts81.43
Price Target9.44 (239.57%)
EPS Next Y61.09%
Revenue Next Year15.11%
LFMD Analyst EstimatesLFMD Analyst Ratings

LFMD Ownership

Ownership
Inst Owners43.01%
Ins Owners17.81%
Short Float %12.41%
Short Ratio4.17
LFMD Ownership

LFMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
VEEV VEEVA SYSTEMS INC-CLASS A19.8828.272B
DOCS DOXIMITY INC-CLASS A14.294.564B
WAY WAYSTAR HOLDING CORP13.574.159B
HTFL HEARTFLOW INC N/A1.915B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP231.731.099B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A1.078B
CERT CERTARA INC11.921.062B
SDGR SCHRODINGER INC N/A833.095M
TDOC TELADOC HEALTH INC N/A792.754M
GDRX GOODRX HOLDINGS INC-CLASS A4.94739.957M

About LFMD

Company Profile

LFMD logo image LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The firm owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.

Company Info

LIFEMD INC

236 Fifth Avenue, Suite 400

New York City NEW YORK 10022 US

CEO: Justin Schreiber

Employees: 304

LFMD Company Website

LFMD Investor Relations

Phone: 18663515907

LIFEMD INC / LFMD FAQ

What does LIFEMD INC do?

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The firm owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.


What is the current price of LFMD stock?

The current stock price of LFMD is 2.78 USD. The price decreased by -0.71% in the last trading session.


Does LFMD stock pay dividends?

LFMD does not pay a dividend.


What is the ChartMill rating of LIFEMD INC stock?

LFMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is LFMD stock listed?

LFMD stock is listed on the Nasdaq exchange.


Can you provide the growth outlook for LIFEMD INC?

The Revenue of LIFEMD INC (LFMD) is expected to grow by 15.11% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the short interest for LFMD stock?

The outstanding short interest for LIFEMD INC (LFMD) is 12.41% of its float.